AnaptysBio Inc
NASDAQ:ANAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AnaptysBio Inc
NASDAQ:ANAB
|
US |
|
F
|
Fujitsu General Ltd
SWB:29F
|
JP |
|
RHB Bank Bhd
OTC:RHBAF
|
MY |
|
Endeavour Silver Corp
TSX:EDR
|
CA |
|
Dampskibsselskabet Norden A/S
CSE:DNORD
|
DK |
|
P
|
Procter & Gamble Co
DUS:PRG
|
US |
|
E
|
Elite Express Holding Inc
NASDAQ:ETS
|
US |
|
White Mountains Insurance Group Ltd
NYSE:WTM
|
US |
|
Ascot Resources Ltd
TSX:AOT
|
CA |
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
US |
|
E
|
EBOS Group Ltd
OTC:EBOSY
|
AU |
|
Valley National Bancorp
NASDAQ:VLY
|
US |
Bankruptcy Probability
AnaptysBio Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AnaptysBio Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
AnaptysBio Inc
NASDAQ:ANAB
|
1.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
37.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AnaptysBio Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AnaptysBio Inc has total debt of 276.5m USD. This includes both short-term (0 USD) and long-term (276.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
